Publications by authors named "Franck Assayag"

25Publications

Combination of Carboplatin and Bevacizumab Is an Efficient Therapeutic Approach in Retinoblastoma Patient-Derived Xenografts.

Invest Ophthalmol Vis Sci 2016 Sep;57(11):4916-4926

Laboratory of Preclinical Investigation, Translational Research Department, Paris Sciences et Lettres (PSL) University, Institut Curie, Paris, France 8Department of Medical Oncology, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1167/iovs.15-18725DOI Listing
September 2016

Establishment of an Orthotopic Xenograft Mice Model of Retinoblastoma Suitable for Preclinical Testing.

Ocul Oncol Pathol 2015 Apr 9;1(3):200-6. Epub 2015 Apr 9.

Laboratory of Preclinical Investigation, Department of Translational Research, Paris, France; Department of Medical Oncology, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000370156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847680PMC
April 2015

Supersonic Shear Wave Elastography of Response to Anti-cancer Therapy in a Xenograft Tumor Model.

Ultrasound Med Biol 2016 Apr 30;42(4):924-30. Epub 2015 Dec 30.

Cardiovascular Research Center-PARCC, Université Paris Descartes Sorbonne Paris Cité, UMR-S970, Paris, France; Radiology Department, Université Paris Descartes Sorbonne Paris Cité, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ultrasmedbio.2015.12.001DOI Listing
April 2016

A new model of patient tumor-derived breast cancer xenografts for preclinical assays.

Clin Cancer Res 2007 Jul;13(13):3989-98

U612 Institut National de la Sante et de la Recherche Medicale, Pharmacologie Préclinique Antitumorale, Paris Anatomie et Cytologie Pathologique, Hôpital Trousseau, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-0078DOI Listing
July 2007

Grb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel.

Int J Cancer 2007 Jul;121(2):407-15

Université Paris Descartes, UFR Biomédicale, Laboratoire de Pharmacochimie Moléculaire et Cellulaire, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22674DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755772PMC
July 2007

Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features.

Cancer Res 2007 Jan;67(1):398-407

Physiopathologie Hépatique, UMR 8149 CNRS, Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Université René Descartes-Paris 5, 4 Avenue de l'Observatoire, 75006 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-0594DOI Listing
January 2007

[Design of new anti-tumor agents interrupting deregulated signaling pathways induced by tyrosine kinase proteins. Inhibition of protein-protein interaction involving Grb2].

J Soc Biol 2004 ;198(2):133-7

UFR Biomédicale des Saints Pères, Laboratoire de Pharmacochimie Moléculaire et Cellulaire, FRE 2718 CNRS, U648 INSERM, 45, rue des Saints-Pères, 75270 Paris Cedex 06.

View Article

Download full-text PDF

Source
December 2004